Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapport Therapeutics (RAPP) Prepaid Assets (2023 - 2026)

Rapport Therapeutics (RAPP) has 4 years of Prepaid Assets data on record, last reported at $7.8 million in Q1 2026.

  • On a quarterly basis, Prepaid Assets rose 41.4% to $7.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $7.8 million, a 41.4% increase, with the full-year FY2025 number at $7.9 million, up 79.24% from a year prior.
  • Prepaid Assets reached $7.8 million in Q1 2026 per RAPP's latest filing, down from $7.9 million in the prior quarter.
  • Over the last five years, Prepaid Assets for RAPP hit a ceiling of $9.7 million in Q2 2025 and a floor of $1.5 million in Q4 2023.
  • A 4-year average of $6.0 million and a median of $5.5 million in 2025 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: skyrocketed 194.47% in 2024, then soared 41.4% in 2026.
  • Tracing RAPP's Prepaid Assets over 4 years: stood at $1.5 million in 2023, then surged by 194.47% to $4.4 million in 2024, then surged by 79.24% to $7.9 million in 2025, then fell by 2.11% to $7.8 million in 2026.
  • Business Quant data shows Prepaid Assets for RAPP at $7.8 million in Q1 2026, $7.9 million in Q4 2025, and $7.5 million in Q3 2025.